Oxford/AstraZeneca Covid-19 vaccine: a vital opportunity for emerging markets
Oxford University/AstraZeneca Covid-19 vaccine, based on viral vector technology and now approved by UK authorities, will be vital for developing countries. Compared to mRNA based vaccines, it is cheaper to make and can be stored at standard refrigeration temperature, making it easier to use in poorer and harder-to-reach parts of the world.
Fantastic achievement !
#postcovid19 #innovation #launch #vaccinessavelives
